In terms of hepatic and renal function, the activities of serum ALT, AST, Cr, and BUN were significantly increased in the T2DM model rats compared to the Control group, and these parameters were significantly decreased in the MET and BHRS treatment groups compared to those in the T2DM group. This evidence concerns the gene GPT and type 2 diabetes mellitus.